(Q38358558)

2 September 2017

Strategies to link innate and adaptive immunity when designing vaccine adjuvants (English)

1 reference

2 September 2017

7

Robert E W Hancock

1 reference

2 September 2017

9

Volker Gerdts

1 reference

2 September 2017

5

Lorne A Babiuk

1 reference

2 September 2017

6

George Mutwiri

1 reference

2 September 2017

1

Srinivas Garlapati

1 reference

2 September 2017

Marina Facci

2

1 reference

2 September 2017

Monika Polewicz

series ordinal

3

1 reference

2 September 2017

Stacy Strom

series ordinal

4

1 reference

2 September 2017

Melissa R Elliott

series ordinal

8

1 reference

2 September 2017

language of work or name

1 reference

17 October 2008

1 reference

Veterinary Immunology and Immunopathology

2 September 2017

1 reference

2 September 2017

128

1 reference

2 September 2017

1-3

1 reference

2 September 2017

184-191

1 reference

BAFF and LPS cooperate to induce B cells to become susceptible to CD95/Fas-mediated cell death

2 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.10.298

Mucosal delivery of bacterial antigens and CpG oligonucleotides formulated in biphasic lipid vesicles in pigs

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.10.298

Preparation of hydrogel microspheres by coacervation of aqueous polyphosphazene solutions

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.10.298

Synthesis, properties, and biological activity of poly[di(sodium carboxylatoethylphenoxy)phosphazene].

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.10.298

Innate immunity of the human newborn is polarized toward a high ratio of IL-6/TNF-alpha production in vitro and in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.10.298

Biphasic lipid vesicles (Biphasix) enhance the adjuvanticity of CpG oligonucleotides following systemic and mucosal administration

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.10.298

The human cationic host defense peptide LL-37 mediates contrasting effects on apoptotic pathways in different primary cells of the innate immune system.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.10.298

Toll-like receptor 4-dependent activation of dendritic cells by beta-defensin 2.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.10.298

Mediators of innate immunity that target immature, but not mature, dendritic cells induce antitumor immunity when genetically fused with nonimmunogenic tumor antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.10.298

Toll-dependent selection of microbial antigens for presentation by dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.10.298

TACI, unlike BAFF-R, is solely activated by oligomeric BAFF and APRIL to support survival of activated B cells and plasmablasts

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.10.298

Genetic immunization of neonates

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.10.298

Impact of LL-37 on anti-infective immunity.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.10.298

The human cationic peptide LL-37 induces activation of the extracellular signal-regulated kinase and p38 kinase pathways in primary human monocytes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.10.298

CpG DNA can induce strong Th1 humoral and cell-mediated immune responses against hepatitis B surface antigen in young mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.10.298

Cationic host defense (antimicrobial) peptides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.10.298

Antibody repertoire development in fetal and neonatal piglets. IX. Three pathogen-associated molecular patterns act synergistically to allow germfree piglets to respond to type 2 thymus-independent and thymus-dependent antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.10.298

Depletion of NK cells results in disseminating lethal infection with Bordetella pertussis associated with a reduction of antigen-specific Th1 and enhancement of Th2, but not Tr1 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.10.298

In vitro and in vivo activation induces BAFF and APRIL expression in B cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.10.298

Protection against Bordetella pertussis infection following parenteral or oral immunization with antigens entrapped in biodegradable particles: effect of formulation and route of immunization on induction of Th1 and Th2 cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.10.298

How best to estimate the global burden of pertussis?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.10.298

The cationic antimicrobial peptide LL-37 modulates dendritic cell differentiation and dendritic cell-induced T cell polarization

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.10.298

Encapsulation in liposomal nanoparticles enhances the immunostimulatory, adjuvant and anti-tumor activity of subcutaneously administered CpG ODN.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.10.298

Blood plasmacytoid dendritic cell responses to CpG oligodeoxynucleotides are impaired in human newborns

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.10.298

LL-37, the neutrophil granule- and epithelial cell-derived cathelicidin, utilizes formyl peptide receptor-like 1 (FPRL1) as a receptor to chemoattract human peripheral blood neutrophils, monocytes, and T cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.10.298

Formulation of maltodextrin entrapped in polycaprolactone microparticles for protein and vaccine delivery: effect of size determining formulation process variables of microparticles on the hydrodynamic diameter of BSA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.10.298

Dose sparing of CpG oligodeoxynucleotide vaccine adjuvants by nanoparticle delivery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.10.298

Infection of newborn piglets with Bordetella pertussis: a new model for pertussis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.10.298

Can innate immunity be enhanced to treat microbial infections?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.10.298

Purified neonatal plasmacytoid dendritic cells overcome intrinsic maturation defect with TLR agonist stimulation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.10.298

Antigen co-encapsulated with adjuvants efficiently drive protective T cell immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.10.298

Immunostimulatory DNA as a vaccine adjuvant

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.10.298

TLR4 mediates vaccine-induced protective cellular immunity to Bordetella pertussis: role of IL-17-producing T cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.10.298

CpG oligodeoxynucleotides enhance neonatal resistance to Listeria infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.10.298

CpG oligodeoxynucleotides improve the survival of pregnant and fetal mice following Listeria monocytogenes infection.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.10.298

Synthetic CpG oligodeoxynucleotides augment BAFF- and APRIL-mediated immunoglobulin secretion.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.10.298

Encapsulation of the immune potentiators MPL and RC529 in PLG microparticles enhances their potency

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.10.298

Adjuvant activity of CpG oligodeoxynucleotides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.10.298

Immunogenicity and protective efficacy of a recombinant filamentous haemagglutinin from Bordetella pertussis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.10.298

Therapeutic potential of Toll-like receptor 9 activation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.10.298

CpG oligodeoxynucleotides stimulate cord blood mononuclear cells to produce immunoglobulins.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.10.298

Apoptosis of airway epithelial cells: human serum sensitive induction by the cathelicidin LL-37.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.10.298

Mechanisms for induction of acquired host immunity by neutrophil peptide defensins

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.10.298

In vivo effects of oligodeoxynucleotides containing synthetic immunostimulatory motifs in the immune response to swine streptococcic septicemia vaccine in weaned piglets

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.10.298

Co-administration of porcine-specific CpG oligodeoxynucleotide enhances the immune responses to pseudorabies attenuated virus vaccine in newborn piglets in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.10.298

Analysis of poly(D,L-lactic-co-glycolic acid) nanosphere uptake by human dendritic cells and macrophages in vitro

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.10.298

A Protective Allergy Vaccine Based on CpG- and Protamine-Containing PLGA Microparticles

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.10.298

Effects of different adjuvants on rotavirus antibody responses and protection in mice following intramuscular immunization with inactivated rotavirus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.10.298

Function and therapeutic potential of host defence peptides.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.10.298

Immunity to Bordetella pertussis.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.10.298

Modulation of the TLR-mediated inflammatory response by the endogenous human host defense peptide LL-37.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.10.298

Bovine and human cathelicidin cationic host defense peptides similarly suppress transcriptional responses to bacterial lipopolysaccharide.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.10.298

Poly[di(sodium carboxylatoethylphenoxy)phosphazene] (PCEP) is a potent enhancer of mixed Th1/Th2 immune responses in mice immunized with influenza virus antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.10.298

Uptake of poly(D,L-lactic-co-glycolic acid) microspheres by antigen-presenting cells in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.10.298

Stimulation of innate immune responses by CpG oligodeoxynucleotide in newborn lambs can reduce bovine herpesvirus-1 shedding

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.10.298

Effects of LT-K63 and CpG2006 on phenotype and function of murine neonatal lymphoid cells.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.10.298

Poly[di(carboxylatophenoxy)phosphazene] (PCPP) is a potent immunoadjuvant for an influenza vaccine.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.10.298

Protein release from polyphosphazene matrices

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.10.298

CpG oligodeoxynucleotides protect newborn mice from a lethal challenge with the neurotropic Tacaribe arenavirus.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.10.298

CpG-motifs enhance initial and sustained primary tetanus-specific antibody secreting cell responses in spleen and bone marrow, but are more effective in adult than in neonatal mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.10.298

Pharmacological modulation of interleukin-17-induced GCP-2-, GRO-alpha- and interleukin-8 release in human bronchial epithelial cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.10.298

Cytosine-phosphate-guanine motifs fail to promote T-helper type 1-polarized responses in human neonatal mononuclear cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.10.298

Th-1/Th-2 type cytokine profiles of pig T-cells cultured with antigen-treated monocyte-derived dendritic cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.10.298

The human antimicrobial peptide LL-37 is a multifunctional modulator of innate immune responses

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.10.298

An anti-infective peptide that selectively modulates the innate immune response.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.10.298

An alpha-helical cationic antimicrobial peptide selectively modulates macrophage responses to lipopolysaccharide and directly alters macrophage gene expression

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.10.298

The challenges of vaccine responses in early life: selected examples

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.10.298

beta-Defensins chemoattract macrophages and mast cells but not lymphocytes and dendritic cells: CCR6 is not involved.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.10.298

Incorporation of CpG oligonucleotide ligand into protein-loaded particle vaccines promotes antigen-specific CD8 T-cell immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.10.298

Nonmethylated CG motifs packaged into virus-like particles induce protective cytotoxic T cell responses in the absence of systemic side effects

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.10.298

A CpG-containing oligodeoxynucleotide as an efficient adjuvant counterbalancing the Th1/Th2 immune response in diphtheria-tetanus-pertussis vaccine

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.10.298

Porcine peripheral blood dendritic cells and natural interferon-producing cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.10.298

Upon TLR9 signaling, CD5+ B cells control the IL-12-dependent Th1-priming capacity of neonatal DCs.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.10.298

Nasal immunization studies using liposomes loaded with tetanus toxoid and CpG-ODN

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.10.298

Induction of systemic and mucosal immune responses by intranasal administration of alginate microspheres encapsulated with tetanus toxoid and CpG-ODN.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.10.298

Defensins act as potent adjuvants that promote cellular and humoral immune responses in mice to a lymphoma idiotype and carrier antigens

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.10.298

Functional responses of human neonatal B lymphocytes to antigen receptor cross-linking and CpG DNA.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.10.298

Monocyte-chemotactic activity of defensins from human neutrophils

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.10.298

Cooperation of Toll-like receptor signals in innate immune defence

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.10.298

Differential regulation of porcine beta-defensins 1 and 2 upon Salmonella infection in the intestinal epithelial cell line IPI-2I.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.10.298

Combination of adsorption by porous CaCO3 microparticles and encapsulation by polyelectrolyte multilayer films for sustained drug delivery

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.10.298

Priming of immune responses to hepatitis B surface antigen in young mice immunized in the presence of maternally derived antibodies

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.10.298

Immune mechanisms and therapeutic potential of CpG oligodeoxynucleotides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.10.298

Evaluation of cholera vaccines formulated with toxin-coregulated pilin peptide plus polymer adjuvant in mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.10.298

Multiple roles of antimicrobial defensins, cathelicidins, and eosinophil-derived neurotoxin in host defense

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.10.298

Beta-defensins: linking innate and adaptive immunity through dendritic and T cell CCR6

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.10.298

The role of mammalian antimicrobial peptides and proteins in awakening of innate host defenses and adaptive immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.10.298

Efficient immunization and cross-priming by vaccine adjuvants containing TLR3 or TLR9 agonists complexed to cationic liposomes

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.10.298

Delivery by Cationic Gelatin Nanoparticles Strongly Increases the Immunostimulatory Effects of CpG Oligonucleotides

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.VETIMM.2008.10.298

10.1016/J.VETIMM.2008.10.298

7 January 2021

Identifiers

DOI

1 reference

2 September 2017

1 reference